14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma

Yousuke Kuroda, Shinichi Aishima, Akinobu Taketomi, Yunosuke Nishihara, Tomohiro Iguchi, Kenichi Taguchi, Yoshihiko Maehara, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The 14-3-3σ gene has been implicated in G2/M cell cycle arrest by p53, and the loss of 14-3-3σ protein expression has been reported in diverse human cancers. However, the role of 14-3-3σ in the signaling pathway of the cell cycle in the progression of intrahepatic cholangiocarcinoma has not been well understood. To clarify the role of 14-3-3σ, we examined the protein expressions of 14-3-3σ, cyclin B1, and p53 in 93 cases of intrahepatic cholangiocarcinoma by immunohistochemical staining. We also examined the correlation between these expressions and survival rate and clinicopathologic factors such as sex, age, tumor grade (ie, pathologic differentiation, tumor size, lymphatic permeation, vascular invasion, perineural invasion, lymph node metastasis), and tumor stage. Positive 14-3-3σ protein expression (>30% of tumor cells) was observed in 67.7% (63/93) of cases of intrahepatic cholangiocarcinoma and was inversely correlated with cyclin B1 expression. No correlation was found between 14-3-3σ expression and p53 expression or clinicopathologic factors; however, decreased 14-3-3σ expression was an independent prognostic factor by multivariate survival analysis (P = .0282). Extensive methylation of 14-3-3σ was found by methylation-specific polymerase chain reaction and sequence; however, no significant correlation was detected between methylation states and protein expression. These results indicate that depressed 14-3-3σ protein is involved in the uncontrolled cell cycle in intrahepatic cholangiocarcinoma and that the decreased expression of 14-3-3σ protein is a significant indicator of poor prognosis for patients with intrahepatic cholangiocarcinoma.

Original languageEnglish
Pages (from-to)1014-1022
Number of pages9
JournalHuman Pathology
Volume38
Issue number7
DOIs
Publication statusPublished - Jul 1 2007

Fingerprint

14-3-3 Proteins
Cholangiocarcinoma
Cell Cycle
Down-Regulation
Methylation
Cyclin B1
Neoplasms
G2 Phase Cell Cycle Checkpoints
Survival Analysis
Blood Vessels
Multivariate Analysis
Survival Rate
Lymph Nodes
Staining and Labeling
Neoplasm Metastasis
Polymerase Chain Reaction
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma. / Kuroda, Yousuke; Aishima, Shinichi; Taketomi, Akinobu; Nishihara, Yunosuke; Iguchi, Tomohiro; Taguchi, Kenichi; Maehara, Yoshihiko; Tsuneyoshi, Masazumi.

In: Human Pathology, Vol. 38, No. 7, 01.07.2007, p. 1014-1022.

Research output: Contribution to journalArticle

Kuroda, Y, Aishima, S, Taketomi, A, Nishihara, Y, Iguchi, T, Taguchi, K, Maehara, Y & Tsuneyoshi, M 2007, '14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma', Human Pathology, vol. 38, no. 7, pp. 1014-1022. https://doi.org/10.1016/j.humpath.2006.12.014
Kuroda, Yousuke ; Aishima, Shinichi ; Taketomi, Akinobu ; Nishihara, Yunosuke ; Iguchi, Tomohiro ; Taguchi, Kenichi ; Maehara, Yoshihiko ; Tsuneyoshi, Masazumi. / 14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma. In: Human Pathology. 2007 ; Vol. 38, No. 7. pp. 1014-1022.
@article{52a17e3713444a46a5fc2517a77535d0,
title = "14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma",
abstract = "The 14-3-3σ gene has been implicated in G2/M cell cycle arrest by p53, and the loss of 14-3-3σ protein expression has been reported in diverse human cancers. However, the role of 14-3-3σ in the signaling pathway of the cell cycle in the progression of intrahepatic cholangiocarcinoma has not been well understood. To clarify the role of 14-3-3σ, we examined the protein expressions of 14-3-3σ, cyclin B1, and p53 in 93 cases of intrahepatic cholangiocarcinoma by immunohistochemical staining. We also examined the correlation between these expressions and survival rate and clinicopathologic factors such as sex, age, tumor grade (ie, pathologic differentiation, tumor size, lymphatic permeation, vascular invasion, perineural invasion, lymph node metastasis), and tumor stage. Positive 14-3-3σ protein expression (>30{\%} of tumor cells) was observed in 67.7{\%} (63/93) of cases of intrahepatic cholangiocarcinoma and was inversely correlated with cyclin B1 expression. No correlation was found between 14-3-3σ expression and p53 expression or clinicopathologic factors; however, decreased 14-3-3σ expression was an independent prognostic factor by multivariate survival analysis (P = .0282). Extensive methylation of 14-3-3σ was found by methylation-specific polymerase chain reaction and sequence; however, no significant correlation was detected between methylation states and protein expression. These results indicate that depressed 14-3-3σ protein is involved in the uncontrolled cell cycle in intrahepatic cholangiocarcinoma and that the decreased expression of 14-3-3σ protein is a significant indicator of poor prognosis for patients with intrahepatic cholangiocarcinoma.",
author = "Yousuke Kuroda and Shinichi Aishima and Akinobu Taketomi and Yunosuke Nishihara and Tomohiro Iguchi and Kenichi Taguchi and Yoshihiko Maehara and Masazumi Tsuneyoshi",
year = "2007",
month = "7",
day = "1",
doi = "10.1016/j.humpath.2006.12.014",
language = "English",
volume = "38",
pages = "1014--1022",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - 14-3-3σ negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma

AU - Kuroda, Yousuke

AU - Aishima, Shinichi

AU - Taketomi, Akinobu

AU - Nishihara, Yunosuke

AU - Iguchi, Tomohiro

AU - Taguchi, Kenichi

AU - Maehara, Yoshihiko

AU - Tsuneyoshi, Masazumi

PY - 2007/7/1

Y1 - 2007/7/1

N2 - The 14-3-3σ gene has been implicated in G2/M cell cycle arrest by p53, and the loss of 14-3-3σ protein expression has been reported in diverse human cancers. However, the role of 14-3-3σ in the signaling pathway of the cell cycle in the progression of intrahepatic cholangiocarcinoma has not been well understood. To clarify the role of 14-3-3σ, we examined the protein expressions of 14-3-3σ, cyclin B1, and p53 in 93 cases of intrahepatic cholangiocarcinoma by immunohistochemical staining. We also examined the correlation between these expressions and survival rate and clinicopathologic factors such as sex, age, tumor grade (ie, pathologic differentiation, tumor size, lymphatic permeation, vascular invasion, perineural invasion, lymph node metastasis), and tumor stage. Positive 14-3-3σ protein expression (>30% of tumor cells) was observed in 67.7% (63/93) of cases of intrahepatic cholangiocarcinoma and was inversely correlated with cyclin B1 expression. No correlation was found between 14-3-3σ expression and p53 expression or clinicopathologic factors; however, decreased 14-3-3σ expression was an independent prognostic factor by multivariate survival analysis (P = .0282). Extensive methylation of 14-3-3σ was found by methylation-specific polymerase chain reaction and sequence; however, no significant correlation was detected between methylation states and protein expression. These results indicate that depressed 14-3-3σ protein is involved in the uncontrolled cell cycle in intrahepatic cholangiocarcinoma and that the decreased expression of 14-3-3σ protein is a significant indicator of poor prognosis for patients with intrahepatic cholangiocarcinoma.

AB - The 14-3-3σ gene has been implicated in G2/M cell cycle arrest by p53, and the loss of 14-3-3σ protein expression has been reported in diverse human cancers. However, the role of 14-3-3σ in the signaling pathway of the cell cycle in the progression of intrahepatic cholangiocarcinoma has not been well understood. To clarify the role of 14-3-3σ, we examined the protein expressions of 14-3-3σ, cyclin B1, and p53 in 93 cases of intrahepatic cholangiocarcinoma by immunohistochemical staining. We also examined the correlation between these expressions and survival rate and clinicopathologic factors such as sex, age, tumor grade (ie, pathologic differentiation, tumor size, lymphatic permeation, vascular invasion, perineural invasion, lymph node metastasis), and tumor stage. Positive 14-3-3σ protein expression (>30% of tumor cells) was observed in 67.7% (63/93) of cases of intrahepatic cholangiocarcinoma and was inversely correlated with cyclin B1 expression. No correlation was found between 14-3-3σ expression and p53 expression or clinicopathologic factors; however, decreased 14-3-3σ expression was an independent prognostic factor by multivariate survival analysis (P = .0282). Extensive methylation of 14-3-3σ was found by methylation-specific polymerase chain reaction and sequence; however, no significant correlation was detected between methylation states and protein expression. These results indicate that depressed 14-3-3σ protein is involved in the uncontrolled cell cycle in intrahepatic cholangiocarcinoma and that the decreased expression of 14-3-3σ protein is a significant indicator of poor prognosis for patients with intrahepatic cholangiocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=34250160930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250160930&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2006.12.014

DO - 10.1016/j.humpath.2006.12.014

M3 - Article

C2 - 17391729

AN - SCOPUS:34250160930

VL - 38

SP - 1014

EP - 1022

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 7

ER -